You might say that Express Scripts has a bad case of the blues lately. Its stock plummeted in the weeks following a public statement by Anthem, the largest Blue Cross and Blue Shield plan, that it ...

The Federal Trade Commission has announced what it called a “landmark settlement” with Express Scripts over insulin pricing.

Citron Research’s tweet suggesting President-elect Donald Trump begin his war on drug pricing with pharmacy benefit manager Express Scripts caused the company’s stock to fall as much as 9 percent ...

The Federal Trade Commission has paused its settlement review involving Express Scripts, a key Pharmacy Benefit Manager tied to Cigna Group's Evernorth segment. This pause directly affects Cigna Group ...

The settlement comes after the FTC in September 2024 brought action against three prescription drug benefit managers, including Express Scripts, alleging the companies were artificially inflating the ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "The fact is that in the unlikely event the ...